Praxis Precision Medicines (PRAX) Total Current Liabilities (2022 - 2025)
Historic Total Current Liabilities for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $52.9 million.
- Praxis Precision Medicines' Total Current Liabilities rose 6092.94% to $52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 6092.94%. This contributed to the annual value of $37.6 million for FY2024, which is 13842.78% up from last year.
- Latest data reveals that Praxis Precision Medicines reported Total Current Liabilities of $52.9 million as of Q3 2025, which was up 6092.94% from $48.6 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Total Current Liabilities ranged from a high of $52.9 million in Q3 2025 and a low of $15.7 million during Q4 2023
- In the last 4 years, Praxis Precision Medicines' Total Current Liabilities had a median value of $32.9 million in 2024 and averaged $32.3 million.
- In the last 5 years, Praxis Precision Medicines' Total Current Liabilities plummeted by 5414.47% in 2023 and then soared by 13842.78% in 2024.
- Over the past 4 years, Praxis Precision Medicines' Total Current Liabilities (Quarter) stood at $34.3 million in 2022, then crashed by 54.14% to $15.7 million in 2023, then surged by 138.43% to $37.6 million in 2024, then soared by 40.83% to $52.9 million in 2025.
- Its last three reported values are $52.9 million in Q3 2025, $48.6 million for Q2 2025, and $39.5 million during Q1 2025.